Evaluation of a Transitional Care Program After Hospitalization for Heart Failure in an Integrated Health Care System.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 12 2020
Historique:
entrez: 3 12 2020
pubmed: 4 12 2020
medline: 28 1 2021
Statut: epublish

Résumé

Prompted by null findings from several care transition trials and practice changes for heart failure in recent years, leaders from a large integrated health care system aimed to reassess the outcomes of its 10-year multicomponent transitional care program for heart failure (HF-TCP). To examine the association of the individual HF-TCP components and their bundle with the primary outcome of all-cause 30-day inpatient or observation stay readmissions. This retrospective cohort study included patients enrolled in the HF-TCP during an inpatient encounter for heart failure at 13 Kaiser Permanente Southern California hospitals from January 1, 2013, to October 31, 2018, who were followed up from discharge until 30 days, readmission, or death. Data were analyzed from May 7, 2019, to May 1, 2020, with additional review from September 2 to October 1, 2020. Patients received 1 home health visit or telecare (telephone) visit from a registered nurse within 2 days of hospital discharge, a heart failure care manager call within 7 days, and a clinic visit with a physician or a nurse practitioner within 7 days. Multivariable proportional hazards regression models were used to estimate the probability of 30-day readmission for those who received the individual or bundled HF-TCP components compared with those who did not. A total of 26 128 patients were included; 57.0% were male, and the mean (SD) age was 73 (13) years. The 30-day readmission rate was 18.1%. Both exposure to a home health visit within 2 days of discharge (hazard ratio [HR], 1.03; 95% CI, 0.96-1.10) and a 7-day heart failure case manager call (HR, 1.08; 95% CI, 0.99-1.18) compared with no visit or call were not associated with a lower rate of readmission. Completion of a 7-day clinic visit was associated with a lower readmission rate (HR, 0.88; 95% CI, 0.81-0.94) compared with no clinic visit. There were no synergistic effects of all 3 components compared with clinic visit alone (HR, 1.05; 95% CI, 0.87-1.28). This study found that HF-TCP as a whole was not associated with a reduction in 30-day readmission rates, although a follow-up clinic visit within 7 days of discharge may be helpful. These findings highlight the importance of continuous quality improvement and refinement of existing clinical programs.

Identifiants

pubmed: 33270125
pii: 2773492
doi: 10.1001/jamanetworkopen.2020.27410
pmc: PMC7716192
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2027410

Références

Clin Med Insights Cardiol. 2019 Jul 10;13:1179546819861396
pubmed: 31316270
Am Heart J. 2019 Jun;212:101-112
pubmed: 30978555
J Am Coll Cardiol. 2017 Oct 10;70(15):1919-1930
pubmed: 28982506
Circ Heart Fail. 2019 Jan;12(1):e005171
pubmed: 30630340
Med Care. 2013 May;51(5):446-53
pubmed: 23579354
Lancet Glob Health. 2020 Mar;8(3):e411-e422
pubmed: 32087174
Ont Health Technol Assess Ser. 2017 May 25;17(8):1-37
pubmed: 28638496
Arch Intern Med. 2006 Sep 25;166(17):1822-8
pubmed: 17000937
J Am Coll Cardiol. 2017 Jul 18;70(3):331-341
pubmed: 28705314
Ann Intern Med. 2011 Oct 18;155(8):520-8
pubmed: 22007045
J Am Geriatr Soc. 2017 Aug;65(8):1748-1755
pubmed: 28369687
Circ Heart Fail. 2016 Jan;9(1):
pubmed: 26754624
CMAJ. 2010 Apr 6;182(6):551-7
pubmed: 20194559
Eur J Heart Fail. 2017 Nov;19(11):1427-1443
pubmed: 28233442
JAMA Intern Med. 2018 Apr 1;178(4):511-519
pubmed: 29482218
JAMA Intern Med. 2017 Jul 1;177(7):975-985
pubmed: 28558095
Circ Heart Fail. 2016 Jun;9(6):
pubmed: 27301467
JAMA Intern Med. 2016 Mar;176(3):310-8
pubmed: 26857383
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
JAMA. 2019 Feb 26;321(8):753-761
pubmed: 30806695
JAMA Intern Med. 2017 Jan 1;177(1):132-135
pubmed: 27893040
JACC Heart Fail. 2015 Oct;3(10):765-73
pubmed: 26364256
Am Heart J. 2018 Oct;204:202-204
pubmed: 30100051
JAMA. 1999 Feb 17;281(7):613-20
pubmed: 10029122
BMJ. 2019 Aug 12;366:l4563
pubmed: 31405902
Am J Epidemiol. 2005 Nov 15;162(10):1016-23
pubmed: 16192344
J Am Geriatr Soc. 2004 May;52(5):675-84
pubmed: 15086645
Circulation. 2005 Sep 20;112(12):e154-235
pubmed: 16160202
JAMA Intern Med. 2014 Jul;174(7):1095-107
pubmed: 24820131
JAMA Intern Med. 2015 May;175(5):725-32
pubmed: 25822284

Auteurs

Aileen Baecker (A)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.

Merry Meyers (M)

Regional Offices, Kaiser Permanente Southern California, Pasadena.

Sandra Koyama (S)

Baldwin Park Medical Center, Kaiser Permanente Southern California, Pasadena.

Maria Taitano (M)

South Bay Medical Center, Kaiser Permanente Southern California, Pasadena.

Heather Watson (H)

Regional Offices, Kaiser Permanente Southern California, Pasadena.

Mary Machado (M)

Regional Offices, Kaiser Permanente Southern California, Pasadena.

Huong Q Nguyen (HQ)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH